Prostate cancer: Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging

Radiology

Volumn 200, Issue 2, 1996, Pages 489-496

  Kurhanewicz, John ^a,b   Vigneron, Daniel B ^a   Hricak, Hedvig ^a   Parivar, Farhad ^a   Nelson, Sarah J ^a   Shinohara, Katsuto ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cryotherapy; Magnetic resonance(MR), spectroscopy; Prostate, MR; Prostate, neoplasms

Indexed keywords

CHOLINE; CITRIC ACID; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CRYOSURGERY; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE; THREE DIMENSIONAL IMAGING;

EID: 0029890838     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.200.2.8685346     Document Type: Article

References (36)

1. Weider J, Schmidt G, Casola E, vanSonnenberg E, Stainken BF, Parsons CL. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol 1995; 154:435-441.
2. Roobottom CA, Jurriaans E, Lanigan D, Dubbins PA, Choa G. Endosonographic monitoring of transurethral cryoprostatectomy. Clin Radiol 1993; 48:241-243.
3. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72:1291-1299.
4. Onik G, Porterfield B, Rubinsky B, Cohen J. Percutaneous transperineal prostate cryosurgery using transrectal ultrasound guidance: animal model. Urology 1991; 37:277-281.
5. Onik G, Cobb C, Cohen J, Zabkar J, Porterfield B. US characteristics of frozen prostate. Radiology 1988; 168:629-631.
6. Miller RJ, Cohen JK, Merlotti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology 1994; 44:170-174.
7. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992; 70:291-301.
8. Ronnett BM, Carmichael MJ, Carter HB, Epstein JI. Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels? J Urol 1993; 386-389.
9. Chen M, Hricak H, Kalbhen CL, et al. Hormonal ablation of prostate cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR 1996; 166:1157-1163.
10. Kalbhen CL, Hricak H, Chen M, et al. MRI findings following cryosurgery for prostate cancer. Radiology 1996; 198:807-811.
11. Hricak H. The prostate gland. In: Hricak H, Carrington BM, eds. MRI of the pelvis. London, England: Martin Dunitz, 1991; 249-311.
12. 3) spatial resolution. Radiology 1996; 198:795-805.
13. Hricak H, White S, Vigneron D, et al. MR imaging in the staging of adenocarcinoma of the prostate: comparison between phased array and endorectal coil. Radiology 1994; 193:703-709.
14. Hricak H, Kurhanewicz J, Proctor E, Bruce N, Vigneron DB. Phased-array endorectal coil MRI of prostate cancer: GE Clinical Symposium 1994. Milwaukee, Wis: GE Medical Systems, 1994; 7:1-12.
15. Kier R, Wain S, Troiano R. Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. AJR 1993; 161: 601-606.
16. Nghiem HV, Herfkens RJ, Francis IR, et al. The pelvis: T2-weighted fast spin-echo MR imaging. Radiology 1992; 185:213-217.
17. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508:333-348.
18. Pauly J, Le Roux P, Nishimura DAM. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm. IEEE Trans Med Imaging 1991; 10:53-65.
19. Mulkern RV, Bowers JL. Calculating spectral modulations of AB systems during PRESS acquisitions (letter). Magn Reson Med 1993; 30:518.
20. Mulkern RV, Bowers J. Density matrix calculations of AB spectra from multipulse sequences: quantum mechanics meets in vivo spectroscopy. Concepts Magn Reson 1994; 6:1-23.
21. Schick F, Bongers H, Kurz S, Jung WI, Pfeffer M, Lutz O. Localized proton MR spectroscopy of citrate in vitro and of the prostate in vivo at 1.5 T. Magn Reson Med 1993; 29:38-43.
22. 1H MRS data for the assessment of response to therapy in patients with brain tumors. In: Proceedings of the Society of Magnetic Resonance 1995. Berkeley, Calif: Society of Magnetic Resonance, 1995; 2:1960.
23. Moyher SE, Vigneron DB, Nelson SJ. Surface coil MR imaging of the human brain with an analytic reception profile correction. JMRI 1995; 5:139-144.
24. Vigneron DB, Nelson SJ, Moyher S, Kelley DAC, Kurhanewicz J, Hricak H. An analytical correction of MR images obtained with endorectal or surface coils. JMRI 1993; 3(P):142.
25. Nelson SJ, Brown TR. A new method for automatic quantification of 1-D spectra with low signal to noise ratio. J Magn Reson 1987; 75:229-243.
26. Nelson S, Brown T. A study of the accuracy of quantification which can be obtained from 1-D NMR spectra using the PIQABLE algorithm. J Magn Reson 1989; 84:95-109.
27. Bracewell RN. The Fourier transform and its applications. New York, NY: McGrawHill 1978; 104-107.
28. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA 1994; 272:773-780.
29. Montie JE. Counseling the patient with localized prostate cancer. Urology 1994; 43(suppl 2):36-40.
30. Gage AA. Cryosurgery in the treatment of cancer. Surg Gynecol Obstet 1992; 174: 73-92.
31. Zietman AL, Coen JJ, Shipley WU, Althausen AF. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure. Urology 1993; 42:292-299.
32. Parkins T. Concern grows over prostate cancer treatment options. J Natl Cancer Inst 1994; 86:897-898.
33. Link P, Freiha FS. Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology 1991; 37:189-192.
34. Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as a in vivo marker to discriminate prostatic cancer from benign prostatic hyperplasia and normal prostatic peripheral zone: detection via localized proton spectroscopy. Urology 1995; 45:1-9.
35. Graham GD, Blamire AM, Howseman AM, et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 1992; 23:333-340.
36. Barker PB, Gillard JH, van ZP, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994; 192:723-732.